Phase III KEYNOTE-585 study of chemotherapy (Chemo) + pembrolizumab (Pembro) vs chemo + placebo as neoadjuvant/adjuvant treatment for patients (pts) with gastric or gastroesophageal junction (G/GEJ) cancer Meeting Abstract

  

Authors:	Bang, Y. J.; Van Cutsem, E.; Fuchs, C. S.; Ohtsu, A.; Tabernero, J.; Ilson, D. H.; Hyung, W. J.; Strong, V. E.; Goetze, T. O.; Yoshikawa, T.; Tang, L. H.; Hwang, P. M. T.; Adelberg, D.; Shitara, K.
Abstract Title:	Phase III KEYNOTE-585 study of chemotherapy (Chemo) + pembrolizumab (Pembro) vs chemo + placebo as neoadjuvant/adjuvant treatment for patients (pts) with gastric or gastroesophageal junction (G/GEJ) cancer
Meeting Title:	43rd ESMO Congress (ESMO 2018)
Journal Title:	Annals of Oncology
Volume:	29
Issue:	Suppl. 8
Meeting Dates:	2018 Oct 19-23
Meeting Location:	Munich, Germany
ISSN:	0923-7534
Publisher:	Oxford University Press
Date Published:	2018-10-01
Start Page:	mdy282.167
Language:	English
ACCESSION:	WOS:000459277301363
PROVIDER:	wos
DOI:	10.1093/annonc/mdy282.167
Notes:	Meeting Abstract: 784TiP -- Appears on page viii268 of the abstract book -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/145129